These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38745673)

  • 1. Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis.
    Dekeyser C; De Kesel P; Cambron M; Vanopdenbosch L; Van Hijfte L; Vercammen M; Laureys G
    Front Immunol; 2024; 15():1385231. PubMed ID: 38745673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa Free Light Chains and IgG Combined in a Novel Algorithm for the Detection of Multiple Sclerosis.
    Gudowska-Sawczuk M; Tarasiuk J; Kułakowska A; Kochanowicz J; Mroczko B
    Brain Sci; 2020 May; 10(6):. PubMed ID: 32471086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the N-latex serum free light chain assay on the Siemens BNII analyzer and agreement with The Binding Site FreeLite assay on the SPA
    White-Al Habeeb NMA; Earle T; Spencer M; Blasutig IM
    Clin Biochem; 2018 Jan; 51():90-96. PubMed ID: 28512013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.
    Ferraro D; Trovati A; Bedin R; Natali P; Franciotta D; Santangelo M; Camera V; Vitetta F; Varani M; Trenti T; Gastaldi M; De Biasi S; Nasi M; Pinti M; Meletti S; Sola P
    Eur J Neurol; 2020 Mar; 27(3):461-467. PubMed ID: 31710409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
    Bayart JL; Muls N; van Pesch V
    Acta Neurol Scand; 2018 Oct; 138(4):352-358. PubMed ID: 29900542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
    Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
    Front Immunol; 2019; 10():641. PubMed ID: 30984199
    [No Abstract]   [Full Text] [Related]  

  • 7. Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis.
    Fischer C; Arneth B; Koehler J; Lotz J; Lackner KJ
    Clin Chem; 2004 Oct; 50(10):1809-13. PubMed ID: 15271859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis.
    Huss A; Mojib-Yezdani F; Bachhuber F; Fangerau T; Lewerenz J; Otto M; Tumani H; Senel M
    Clin Chim Acta; 2019 Nov; 498():148-153. PubMed ID: 31437445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination.
    Puthenparampil M; Altinier S; Stropparo E; Zywicki S; Poggiali D; Cazzola C; Toffanin E; Ruggero S; Grassivaro F; Zaninotto M; Plebani M; Gallo P
    Mult Scler Relat Disord; 2018 Oct; 25():241-245. PubMed ID: 30130707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands.
    Altinier S; Puthenparampil M; Zaninotto M; Toffanin E; Ruggero S; Gallo P; Plebani M
    Clin Chim Acta; 2019 Sep; 496():117-120. PubMed ID: 31233736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective.
    Toscano S; Chisari CG; Lo Fermo S; Gulino G; Zappia M; Patti F
    J Neurol; 2023 Dec; 270(12):6010-6020. PubMed ID: 37639016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa Index Versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders.
    Ferraro D; Bedin R; Natali P; Franciotta D; Smolik K; Santangelo M; Immovilli P; Camera V; Vitetta F; Gastaldi M; Trenti T; Meletti S; Sola P
    Diagnostics (Basel); 2020 Oct; 10(10):. PubMed ID: 33096861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis.
    Christiansen M; Gjelstrup MC; Stilund M; Christensen T; Petersen T; Jon Møller H
    Clin Chem Lab Med; 2018 Dec; 57(2):210-220. PubMed ID: 30055097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis.
    Duranti F; Pieri M; Centonze D; Buttari F; Bernardini S; Dessi M
    J Neuroimmunol; 2013 Oct; 263(1-2):116-20. PubMed ID: 23916392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal B cell-related markers for an optimized biological investigation of multiple sclerosis patients.
    Feki S; Damak M; Sakka S; Ben Ali Y; Mejdoub S; Bouattour N; Hachicha H; Mhiri C; Masmoudi H
    Sci Rep; 2022 Sep; 12(1):16425. PubMed ID: 36180495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Use of κ Free Light Chains Index as a Screening Test for Multiple Sclerosis.
    Agnello L; Lo Sasso B; Salemi G; Altavilla P; Pappalardo EM; Caldarella R; Meli F; Scazzone C; Bivona G; Ciaccio M
    Lab Med; 2020 Jul; 51(4):402-407. PubMed ID: 31943078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribute of cerebrospinal fluid free light-chain assay in the diagnosis of multiple sclerosis and other neurological diseases in an Italian multicenter study.
    Bernardi G; Biagioli T; Malpassi P; De Michele T; Vecchio D; Repice AM; Lugaresi A; Mirabella M; Torri Clerici V; Crespi I
    Mult Scler; 2022 Aug; 28(9):1364-1372. PubMed ID: 34965771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Long-Term Storage on Serum Free Light Chain Stability.
    Hörber S; Klein R; Peter A
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative diagnostic value of cerebrospinal fluid kappa chains in MS: comparison with other immunoglobulin tests.
    Rudick RA; French CA; Breton D; Williams GW
    Neurology; 1989 Jul; 39(7):964-8. PubMed ID: 2500621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis.
    Hassan-Smith G; Durant L; Tsentemeidou A; Assi LK; Faint JM; Kalra S; Douglas MR; Curnow SJ
    J Neuroimmunol; 2014 Nov; 276(1-2):175-9. PubMed ID: 25146968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.